OSE Immunotherapeutics SA (LON:0RAD)
5.93
-0.23 (-3.66%)
At close: Sep 12, 2025
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of 112.54 million as of September 19, 2025. Its market cap has decreased by -32.84% in one year.
Market Cap
112.54M
Enterprise Value
101.25M
Revenue
69.00M
Ranking
n/a
PE Ratio
3.63
Stock Price
5.93
Market Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has increased from 76.24M to 112.54M, an increase of 47.61%. That is a compound annual growth rate of 3.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 110.78M | -14.59% |
Dec 31, 2024 | 129.69M | 85.55% |
Dec 29, 2023 | 69.90M | -36.14% |
Dec 30, 2022 | 109.46M | -30.57% |
Dec 31, 2021 | 157.65M | 36.38% |
Dec 31, 2020 | 115.60M | 147.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 177.00B |
HSBC Holdings | 174.75B |
Shell | 153.13B |
Unilever | 114.20B |
Rolls-Royce Holdings | 96.19B |
British American Tobacco p.l.c. | 90.16B |
Rio Tinto Group | 79.62B |
BP p.l.c. | 64.73B |